Worth reading
76Important
Scored from 5 of 6 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
39
¥ hundred millionWording
Conditional
How definitive the wording is.Contents of this document
Earnings presentationQ3 FY20265 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥1,016 million+33.8%
Operating profit¥-381 million
Ordinary income¥-413 million
Net income¥-530 million
Selling, general and administrative expenses¥166 million
Results for the three months of the current quarter
Net Sales
¥373 million
Operating profit
¥-77 million
Ordinary income
¥-82 million
Profit before income taxes for the period
¥-78 million
Net income
¥-78 million
Selling, general and administrative expenses
¥166 million
EBITDA
¥-74 million
Full-year earnings forecast
Net Sales
¥1,308 million
Operating profit
¥-486 million
Ordinary income
¥-501 million
Net income for the current fiscal year
¥-502 million
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales77.7%
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Revenue is progressing steadily, while the net loss has exceeded the full-year forecastNew initiatives
- Making コンヴァノ a consolidated subsidiary
- ¥900 million capital increase through a third-party allotment
- ¥3 billion commitment-type term loan facility
- Healthcare M&A and business investment
- Launch of a medical loan business
- Joint development of medical DX solutions
- Launch of a cleansing oil under the total beauty care brand 『≒4.7』
Key KPIsA metric the company considers important as a management benchmark.
- cardéria Ikebukuro store revenueApproximately 1.6x the previous quarter
- Trading card business revenueApproximately 1.4x the previous quarter
Segment results
- Trading card businessNet Sales¥316 million
- Advertising BusinessNet Sales¥52 million
- OtherNet Sales¥4 million
Medium-term management plan targets
- TargetMarket capitalization of ¥20 billionTarget fiscal yearMedium term
- TargetMarket capitalization exceeding ¥4 billionTarget fiscal yearWithin FY ending September 2026
| Item | Details |
|---|---|
| Document type | Earnings presentation |
| Fiscal Period Covered | Q3 FY2026 |
| Net Sales | ¥1,016 million (YoY +33.8%) |
| Operating profit | ¥-381 million |
| Ordinary income | ¥-413 million |
| Net income | ¥-530 million |
| Selling, general and administrative expenses | ¥166 million |
| Results for the three months of the current quarter | Net Sales ¥373 million / Operating profit ¥-77 million / Ordinary income ¥-82 million / Profit before income taxes for the period ¥-78 million / Net income ¥-78 million / Selling, general and administrative expenses ¥166 million / EBITDA ¥-74 million |
| Full-year earnings forecast | Net Sales ¥1,308 million / Operating profit ¥-486 million / Ordinary income ¥-501 million / Net income for the current fiscal year ¥-502 million |
| Progress against full-year forecast | Net Sales 77.7% |
| Self-assessment against the plan | Revenue is progressing steadily, while the net loss has exceeded the full-year forecast |
| Segment results | Segment Trading card business / Net Sales ¥316 million / Year on year against the same period last year Not disclosed, Segment Advertising Business / Net Sales ¥52 million / Year on year against the same period last year Not disclosed, Segment Other / Net Sales ¥4 million / Year on year against the same period last year Not disclosed |
| Key KPIs | Indicator name cardéria Ikebukuro store revenue / Value Approximately 1.6x the previous quarter / Year on year against the same period last year Not disclosed, Indicator name Trading card business revenue / Value Approximately 1.4x the previous quarter / Year on year against the same period last year Not disclosed |
| Medium-term management plan targets | Target Market capitalization of ¥20 billion / Target fiscal year Medium term, Target Market capitalization exceeding ¥4 billion / Target fiscal year Within FY ending September 2026 |
| New initiatives | Making コンヴァノ a consolidated subsidiary, ¥900 million capital increase through a third-party allotment, ¥3 billion commitment-type term loan facility, Healthcare M&A and business investment, Launch of a medical loan business, Joint development of medical DX solutions, Launch of a cleansing oil under the total beauty care brand 『≒4.7』 |
Items this document does not state (16)
Gross Profit MarginOperating profit marginBreakdown of Factors Affecting the ChangeUnit price and quantity metricsNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookFinancial targetsAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company aims to secure growth capital, strengthen its financial base and accelerate decision-making by leveraging コンヴァノ's network of medical institutions, promoting M&A in the healthcare sector, launching a medical loan business, bringing in directors and specialized personnel, and consolidating the allocation of responsibilities. The increase in third-quarter revenue was attributed to growth in the trading card business driven by stronger event initiatives and an expanded range of titles handled on the e-commerce site, as well as lower selling, general and administrative expenses resulting from the reorganization of group companies and other factors.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.